ReviewPublished 12 October 2026Tebentafusp induces systemic immune activation, but tumor immune remodeling remains incompletely validated: a narrative review in metastatic uveal melanomaFrancesca Rifaldi · Filippo De Braud · Michele Del Vecchio · Lorenza Di GuardoFrontiers in Immunologydoi 10.3389/fimmu.2026.1934256
Original ResearchPublished 4 May 2026Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholdersEilidh M Duncan · Jhulia Salviano · Charalampia Kyriakou · Samantha Nier · Simone Oerlemans · Sam Salek · Kate Morgan · Katie JoynerFrontiers in Hematologydoi 10.3389/frhem.2026.1800304